Optimized human peptide found to be an effective antibacterial agent

January 11, 2018 by Bob Yirka, Medical Xpress report
Electron micrograph images of antibiotic-resistant Staphylococcus aureus bacteria being killed by a new therapy called SAAP-148. Credit: A. de Breij et al., Science Translational Medicine (2018)

A team of researchers in the Netherlands has developed an effective antibacterial ointment based on an optimized human peptide. In their paper published in the journal Science Translational Medicine, the group describes developing the synthetic peptide and how well it worked when tested in the lab.

As the search continues for alternatives to antibacterial drugs that have succumbed to , researchers look to the human immune system to see if there might be a way to bolster its strength. In this new effort, the researchers looked at a peptide called LL-37, which is known to help in regulating the immune system in humans and to have bacteria killing properties. The team gave it more strength by shortening its and changing some of its building blocks. The result was a bacteria-killing called SAAP-148. It is able to kill bacteria, the team notes, by piercing their membranes.

The team added the peptide to an ointment and applied it to a biofilm covering a sample of human skin in a petri dish and to wounds on the backs of mice. Doing so, the researchers found, cleared two serious types of bacteria—a strain of MRSA called Staphylococcus aureus and Acinetobacter baumannii, which has become resistant to most current antibiotics. Notably, the ointment was also able to treat biofilms as easily as outlier infections. Biofilms are notoriously difficult to deal with because they shield bacteria from . Notably, neither of the bacteria types tested developed resistance to the peptide even after repeated exposure. And as if all that were not enough, the peptide also overcame a big problem with other antibacterial drugs—the tendency to become bogged down in blood proteins and lipids, which prevent them from reaching an infection site.

Animation illustrating a new therapy to eradicate drug-resistant bacteria growing in biofilms, which are notoriously difficult to treat. Credit: Carla Schaffer / A. de Breij et al. / AAAS

The will continue testing the ointment on other types of infections and bacteria, even as they prepare for clinical trials that will test its effectiveness against atopic dermatitis and infections in burn wounds. They are also looking to see if it might be possible to create an injectable drug containing the peptide that could fight infections inside the body.

Explore further: A small molecule outclasses larger ones in combating drug-resistant bacteria that cause skin infections

More information: Anna de Breij et al. The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms, Science Translational Medicine (2018). DOI: 10.1126/scitranslmed.aan4044

Development of novel antimicrobial agents is a top priority in the fight against multidrug-resistant (MDR) and persistent bacteria. We developed a panel of synthetic antimicrobial and antibiofilm peptides (SAAPs) with enhanced antimicrobial activities compared to the parent peptide, human antimicrobial peptide LL-37. Our lead peptide SAAP-148 was more efficient in killing bacteria under physiological conditions in vitro than many known preclinical- and clinical-phase antimicrobial peptides. SAAP-148 killed MDR pathogens without inducing resistance, prevented biofilm formation, and eliminated established biofilms and persister cells. A single 4-hour treatment with hypromellose ointment containing SAAP-148 completely eradicated acute and established, biofilm-associated infections with methicillin-resistant Staphylococcus aureus and MDR Acinetobacter baumannii from wounded ex vivo human skin and murine skin in vivo. Together, these data demonstrate that SAAP-148 is a promising drug candidate in the battle against antibiotic-resistant bacteria that pose a great threat to human health.

Related Stories

A small molecule outclasses larger ones in combating drug-resistant bacteria that cause skin infections

April 6, 2016
A promising drug candidate to address the growing problem of antibiotic-resistant skin infections has been discovered by A*STAR researchers.

Researchers develop new weapon for hard-to-treat bacterial infections

September 28, 2016
Health workers may soon have a new weapon in the fight against abscesses—difficult-to-treat bacterial infections that lead to millions of emergency-room visits every year.

Recommended for you

Democratizing science: Researchers make neuroscience experiments easier to share, reproduce

March 16, 2018
Over the past few years, scientists have faced a problem: They often cannot reproduce the results of experiments done by themselves or their peers.

Human 'chimeric' cells restore crucial protein in Duchenne muscular dystrophy

March 16, 2018
Cells made by fusing a normal human muscle cell with a muscle cell from a person with Duchenne muscular dystrophy —a rare but fatal form of muscular dystrophy—were able to significantly improve muscle function when implanted ...

Team develops 3-D tissue model of a developing human heart

March 16, 2018
The heart is the first organ to develop in the womb and the first cause of concern for many parents.

Genetic variant discovery to help asthma sufferers

March 16, 2018
Research from the University of Liverpool, published today in Lancet Respiratory Medicine, identifies a genetic variant that could improve the safety and effectiveness of corticosteroids, drugs that are used to treat a range ...

Researchers say use of artificial intelligence in medicine raises ethical questions

March 15, 2018
In a perspective piece, Stanford researchers discuss the ethical implications of using machine-learning tools in making health care decisions for patients.

Study identifies potential drug for treatment of debilitating inherited neurological disease

March 15, 2018
St. Jude Children's Research Hospital scientists have demonstrated in mouse studies that the neurological disease spinal bulbar muscular atrophy (SBMA) can be successfully treated with drugs. The finding paves the way for ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.